ACHIEVE

Something I keep coming back to: the ATTAIN question that gets asked weekly, answered properly. Holding off on any opinion until phase 3 reports. That is not a…

am I the only one who found orforglipron harder than the injections. If this has been answered properly somewhere, link me and I will delete. Daily rather than weekly…

Short version of the title, which is already short: QYB orfo — Medutest came back 99.3% against a claimed 99.0%. Longer version underneath. Numbers, in the order they…

Here it is: anyone else notice oral GLP-1 kicking in around week 56. One person, one log, no control group, so read it accordingly. Why "oral" is doing two completely…

ATTAIN-1 numbers, and why the % is not the headline. I have gone back and forth on this for months. Read both programme names carefully after mixing them up in a…

Short version of the title, which is already short: 6th independent test on SWB — 99.1% on a claimed 99.0%, and the trend is the interesting part. Longer version…

Posting this as a discussion rather than a claim: reading ATTAIN threads from 2024 and half of it aged badly. Milligram comparisons across molecule classes are…

why does nobody talk about ACHIEVE — that is what I am asking, and I have already read the wiki twice. Analytically this is a small-molecule identity and purity…

small win: non-peptide stopped being a problem at week 82. This is a description of what happened to me and not a plan for anybody else. What is actually known, and…

Trying to get a straight answer on this: small molecule means purity testing is a different problem, right. What is actually known, and what is being assumed. Known: it…

8 months in and orforglipron is still the thing I get wrong, logged the same way every week so the comparison is at least internally fair. The relevant figures are 8…

Thinking out loud about this: the ACHIEVE advice in here is 3 years out of date. 3 years — those are the numbers, and they are the ones I am willing to defend. Nothing…

Posting this as a discussion rather than a claim: oral GLP-1 — 12 things I got wrong before I got it right. What is actually known, and what is being assumed. Known: it…

Something I keep coming back to: ATTAIN is doing more work than we give it credit for. Oral semaglutide is a peptide co-formulated with an absorption enhancer and…

79 weeks, 21kg, and non-peptide was the hard part, and the part I actually want to talk about is at the bottom. Numbers, in the order they matter: 79 weeks and 21kg.…

Something I keep coming back to: non-peptide: what the trials say vs what this community says. Holding off on any opinion until phase 3 reports. That is not a…

a pill with no food restrictions and no cold chain changes this entire site, which sounds obvious until you try to state the evidence for it. It is a non-peptide…

non-peptide agonism is a genuinely different engineering problem. I have gone back and forth on this for months. Read both programme names carefully after mixing them…

ACHIEVE-1 glycaemic data vs the injectables, which sounds obvious until you try to state the evidence for it. Spent an evening reading about small-molecule agonism at a…

Posting this as a discussion rather than a claim: reading oral GLP-1 threads from 2024 and half of it aged badly. What is actually known, and what is being assumed.…

what would you tell week-1 you about ACHIEVE. I would rather ask a basic question now than get this wrong quietly for two months. Because it is not a peptide, it is not…

Posting this because the title is the whole finding — CPC orfo — Janoshik came back 98.2% against a claimed 97.5% — and a number without its method is a rumour. The…

Here it is: 12 months in and orforglipron is still the thing I get wrong. One person, one log, no control group, so read it accordingly. The relevant figures are 12…

what happens to the research-peptide supply chain if this lands. I am not trying to be the "source?" guy. I would just like a source. Read both programme names…